← Back to All Filings
Cintas Corp Director Martin Mucci Receives Annual Equity Grants
CINTAS CORP
$CTAS4CIK: 0000723254
Subscribe to track CTAS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction: CINTAS CORP ($CTAS)
**Reporting Owner:** MUCCI MARTIN (Director)
**Filing Date:** 2026-10-29 | **Transaction Date:** 2026-10-28
### Non-Derivative Activity
- **Security:** Common Stock
- **Action:** Grant / Award (Acquisition)
- **Shares:** 459 @ $0.00
- **Post-Transaction Holdings:** 3,583 shares (Direct)
### Derivative Activity
- **Security:** Stock Option (Right to Buy)
- **Action:** Grant / Award
- **Shares Under Option:** 1,648
- **Exercise Price:** $212.81
- **Expiration Date:** 2036-10-28
### Significance
**Low** — Routine director equity compensation award; no open-market purchase or sale.
Comprehensive Analysis
Overview
On October 29, 2026, Cintas Corp ($CTAS) filed a Form 4 detailing routine equity compensation awards for Director Martin Mucci executed on October 28, 2026.
Transaction Details
- Restricted Common Stock: Granted 459 shares of restricted common stock under Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan at an acquisition cost of $0.00. These shares cliff vest on the first anniversary of the grant date.
- Direct Ownership Post-Transaction: 3,583 shares of common stock.
- Derivative Grant: Received 1,648 stock options (Right to Buy) at an exercise price of $212.81 per share with an expiration date of October 28, 2036. The options cliff vest on the first anniversary of the grant date.
Market & Trading Significance
This transaction represents standard annual board equity compensation and carries Low trading significance, as it does not reflect open-market buying or selling activity.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.